Navitas Assets (Cicletanine Business)
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of hypertension drug. The company develops and produces drug, oral drug agents and treatments for pulmonary arterial hypertension.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
- United States
Navitas Assets (Cicletanine Business) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.
Request full access to PitchBookNavitas Assets (Cicletanine Business) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.
Request full access to PitchBook